<SEC-DOCUMENT>0001004878-20-000027.txt : 20200221
<SEC-HEADER>0001004878-20-000027.hdr.sgml : 20200221
<ACCEPTANCE-DATETIME>20200221164750
ACCESSION NUMBER:		0001004878-20-000027
CONFORMED SUBMISSION TYPE:	AW WD
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20200221
DATE AS OF CHANGE:		20200221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEL SCI CORP
		CENTRAL INDEX KEY:			0000725363
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				840916344
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		AW WD
		SEC ACT:		
		SEC FILE NUMBER:	333-233379
		FILM NUMBER:		20640754

	BUSINESS ADDRESS:	
		STREET 1:		8229 BOONE BLVD .
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182
		BUSINESS PHONE:		7035069460

	MAIL ADDRESS:	
		STREET 1:		8229 BOONE BLVD.
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERLEUKIN 2 INC
		DATE OF NAME CHANGE:	19880317
</SEC-HEADER>
<DOCUMENT>
<TYPE>AW WD
<SEQUENCE>1
<FILENAME>withdrawposerror2-20.txt
<DESCRIPTION>LETTER WITHDRAW POS PER ERROR
<TEXT>
                               CEL-SCI CORPORATION
                              8229 Boone Blvd. #802
                                Vienna, VA 22182
                                 (703) 506-9460


                                February 21, 2020


Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549

      Re:  Post-Effective Amendment No. 1 to Registration Statement on Form S-1
           File No. 333-233379


     CEL-SCI  Corporation  (the  "Company")  requests  that the  request for the
withdrawal of the above-captioned Post-Effective Amendment No. 1 to registration
statement  333-233379  be  withdrawn.  The reason  for this  request is that the
previously filed request for withdrawal needed to be signed by the Company.

     No securities were sold by means of the  Post-Effective  Amendment No. 1 to
the registration statement.

                                        Very Truly Yours,

                                        CEL-SCI CORPORATION


                                        /s/ Geert R. Kersten

                                        Geert R. Kersten
                                         Chief Executive Officer






</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
